Moderna, Inc. (LON:0A45)

Moderna Statistics

Total Valuation

Moderna has a market cap or net worth of GBP 8.62 billion. The enterprise value is 4.19 billion.

Market Cap	8.62B
Enterprise Value	4.19B

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	390.73M
Shares Outstanding	n/a
Shares Change (YoY)	+1.31%
Shares Change (QoQ)	+0.52%
Owned by Insiders (%)	6.54%
Owned by Institutions (%)	71.84%
Float	364.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.19
PB Ratio	1.24
P/TBV Ratio	1.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.81
EV / Sales	2.51
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.12

Financial Position

The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.08.

Current Ratio	3.93
Quick Ratio	3.51
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-0.28
Interest Coverage	-432.88

Financial Efficiency

Return on equity (ROE) is -29.32% and return on invested capital (ROIC) is -18.54%.

Return on Equity (ROE)	-29.32%
Return on Assets (ROA)	-15.49%
Return on Invested Capital (ROIC)	-18.54%
Return on Capital Employed (ROCE)	-33.13%
Revenue Per Employee	286,289
Profits Per Employee	-399,675
Employee Count	5,800
Asset Turnover	0.16
Inventory Turnover	12.46

Taxes

Income Tax	-27.53M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.86% in the last 52 weeks. The beta is 1.11, so Moderna's price volatility has been higher than the market average.

Beta (5Y)	1.11
52-Week Price Change	-28.86%
50-Day Moving Average	26.05
200-Day Moving Average	27.49
Relative Strength Index (RSI)	68.99
Average Volume (20 Days)	51,887

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.25

Income Statement

In the last 12 months, Moderna had revenue of GBP 1.66 billion and -2.32 billion in losses. Loss per share was -5.99.

Revenue	1.66B
Gross Profit	-1.79B
Operating Income	-2.58B
Pretax Income	-2.35B
Net Income	-2.32B
EBITDA	-2.42B
EBIT	-2.58B
Loss Per Share	-5.99

Balance Sheet

The company has 3.35 billion in cash and 546.05 million in debt, giving a net cash position of 4.40 billion.

Cash & Cash Equivalents	3.35B
Total Debt	546.05M
Net Cash	4.40B
Net Cash Per Share	n/a
Equity (Book Value)	6.94B
Book Value Per Share	17.75
Working Capital	3.66B

Cash Flow

In the last 12 months, operating cash flow was -1.47 billion and capital expenditures -502.16 million, giving a free cash flow of -1.97 billion.

Operating Cash Flow	-1.47B
Capital Expenditures	-502.16M
Free Cash Flow	-1.97B
FCF Per Share	n/a

Margins

Gross margin is -107.62%, with operating and profit margins of -155.15% and -139.61%.

Gross Margin	-107.62%
Operating Margin	-155.15%
Pretax Margin	-141.26%
Profit Margin	-139.61%
EBITDA Margin	-145.83%
EBIT Margin	-155.15%
FCF Margin	n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.31%
Shareholder Yield	-1.31%
Earnings Yield	-26.90%
FCF Yield	-22.90%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Moderna has an Altman Z-Score of 3.5 and a Piotroski F-Score of 1.

Altman Z-Score	3.5
Piotroski F-Score	1